J&J’s New Insider CEO Brings Expertise From Crucial Pharma Post
- New CEO effective Jan. 3; Gorsky to become executive chairman
- Gorsky departs citing J&J’s strong performance, family health
Joaquin Duato
Photographer: Andrew Harrer/BloombergThis article is for subscribers only.
Johnson & Johnson went to another insider to lead the health-care giant through the pandemic, naming Joaquin Duato to replace longtime veteran Alex Gorsky, and edging up the stock to a record high.
Now vice chairman of the executive committee, Duato will take the reins effective Jan. 3 and take a seat on the company’s board, J&J said in a statement late Thursday. Gorsky, who’s been at the helm for nine years, will become executive chairman.